Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: ANTAGEN BIOSCIENCES INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-06-17 to 2022-04-30
Current total value of award: $599914
Description: EO14042-THE OBJECTIVE OF THIS CONTRACT IS TO USE IMMUNOGENS (ENVS) COMBINED WITH EFFECTIVE MULTIVALENT ANTIGENIC DISPLAY ON NANOPARTICLES (NPS) FOR DELIVERY TO PROMOTE STRONG AND LONG-LIVED NEUTRALIZING ANTIBODY RESPONSES AGAINST HIV AND DIRECT AFFIN